These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36323529)

  • 1. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
    Li J; Qi C; Li Q; Liu F
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
    Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram based on autophagy related genes for predicting the survival in melanoma.
    Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
    BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer.
    Yuan J; Duan F; Zhai W; Song C; Wang L; Xia W; Hua X; Yuan Z; Bi X; Huang J
    Int J Womens Health; 2021; 13():1053-1064. PubMed ID: 34785957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
    Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H
    BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
    Yan C; Liu Q; Jia R
    Front Oncol; 2022; 12():829045. PubMed ID: 35186763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
    Xu Q; Chen Y
    Front Cell Dev Biol; 2021; 9():685379. PubMed ID: 34277626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma.
    Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H
    Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma.
    Ma Y; Zheng S; Xu M; Chen C; He H
    Stem Cells Int; 2023; 2023():6245160. PubMed ID: 37964984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Apoptosis-Related Specific Risk Model for Breast Cancer: From Genomic Analysis to Precision Medicine.
    Li Z; Liu H; Zhang M; Wang J; Peng Q; Jiang N; Wei Y
    Front Biosci (Landmark Ed); 2024 Jun; 29(7):239. PubMed ID: 39082332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.
    Zhao Y; Zhang Y; Dai C; Hong K; Guo Y
    Aging (Albany NY); 2022 Aug; 14(15):6169-6186. PubMed ID: 35939339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
    Ma JY; Liu Q; Liu G; Peng S; Wu G
    Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
    Zhong S; Chen H; Yang S; Feng J; Zhou S
    PeerJ; 2020; 8():e9621. PubMed ID: 33194339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.